XRAY
$12.20+0.47 (+3.96%)
DENTSPLY SIRONA Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Tech...
Recent News
Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares?
This global dental technology firm, with strong recurring revenues, reported a notable insider buy following a year of share price declines.
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
How The Dentsply Sirona (XRAY) Story Is Shifting As Analysts Rework Valuation And Risks
The updated model lifts DENTSPLY SIRONA’s fair value estimate from US$12.97 to US$14.43, putting fresh focus on how the stock’s upside case is being recalibrated. This shift lines up with recent Street work, where several firms have moved price targets higher while keeping a mixed stance on how much execution risk remains. As you read on, you will see how these target changes fit into the evolving narrative and what to watch if you are tracking this story over time. Analyst Price Targets...
A Look At Dentsply Sirona (XRAY) Valuation After Mixed Earnings And Impairment Charges
DENTSPLY SIRONA (XRAY) has been back in focus after its latest quarterly update combined revenue that beat expectations with an adjusted earnings per share miss, softer full year guidance, and fresh impairment charges, keeping sentiment cautious. See our latest analysis for DENTSPLY SIRONA. Recent earnings, new 2026 sales guidance and sizeable non cash impairments have come against a backdrop of a 13.2% 7 day share price decline and an 18.1% 1 year total shareholder return loss, despite a...